Seeking Alpha

EDAP TMS SA (EDAP +19.7%) pops today after earlier reporting test data showing high survival and...

EDAP TMS SA (EDAP +19.7%) pops today after earlier reporting test data showing high survival and salvage rates for patients given its high-intensity focused ultrasound therapy to treat prostate cancer. The study was electronically published in the Journal of Urology, the Official Journal of the American Urological Association.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector